Dianyun Ren

1.1k total citations
25 papers, 708 citations indexed

About

Dianyun Ren is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Dianyun Ren has authored 25 papers receiving a total of 708 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 13 papers in Oncology and 6 papers in Immunology. Recurrent topics in Dianyun Ren's work include Pancreatic and Hepatic Oncology Research (7 papers), interferon and immune responses (5 papers) and Epigenetics and DNA Methylation (4 papers). Dianyun Ren is often cited by papers focused on Pancreatic and Hepatic Oncology Research (7 papers), interferon and immune responses (5 papers) and Epigenetics and DNA Methylation (4 papers). Dianyun Ren collaborates with scholars based in China, United States and Canada. Dianyun Ren's co-authors include Xin Jin, Heshui Wu, Yan Sun, Jingyuan Zhao, Zibo Meng, Yingke Zhou, Zhiqiang Liu, Huan Zhang, Feng Guo and Bo Wang and has published in prestigious journals such as The EMBO Journal, Cancer Research and Science Advances.

In The Last Decade

Dianyun Ren

25 papers receiving 702 citations

Peers

Dianyun Ren
Dianyun Ren
Citations per year, relative to Dianyun Ren Dianyun Ren (= 1×) peers Shucai Yang

Countries citing papers authored by Dianyun Ren

Since Specialization
Citations

This map shows the geographic impact of Dianyun Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dianyun Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dianyun Ren more than expected).

Fields of papers citing papers by Dianyun Ren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dianyun Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dianyun Ren. The network helps show where Dianyun Ren may publish in the future.

Co-authorship network of co-authors of Dianyun Ren

This figure shows the co-authorship network connecting the top 25 collaborators of Dianyun Ren. A scholar is included among the top collaborators of Dianyun Ren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dianyun Ren. Dianyun Ren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ma, Jian, Dianyun Ren, Wei Li, et al.. (2024). CK2-dependent degradation of CBX3 dictates replication fork stalling and PARP inhibitor sensitivity. Science Advances. 10(21). eadk8908–eadk8908. 3 indexed citations
2.
Zhao, Jingyuan, Yan Sun, Yingke Zhou, et al.. (2024). Ubiquitin ligase TRIM15 promotes the progression of pancreatic cancer via the upregulation of the IGF2BP2-TLR4 axis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(5). 167183–167183. 4 indexed citations
3.
Sun, Yan, Xin Jin, Feng Guo, et al.. (2023). MST2 methylation by PRMT5 inhibits Hippo signaling and promotes pancreatic cancer progression. The EMBO Journal. 42(23). e114558–e114558. 16 indexed citations
4.
Yu, Haixin, Jie Chen, Jian Shen, et al.. (2022). HDAC5 Loss Enhances Phospholipid-Derived Arachidonic Acid Generation and Confers Sensitivity to cPLA2 Inhibition in Pancreatic Cancer. Cancer Research. 82(24). 4542–4554. 13 indexed citations
5.
Sun, Yan, et al.. (2022). ITGA2 induces STING expression in pancreatic cancer by inducing DNMT1 degradation. Cellular Oncology. 45(6). 1421–1434. 5 indexed citations
6.
Zhou, Yingke, Xin Jin, Haixin Yu, et al.. (2022). HDAC5 modulates PD-L1 expression and cancer immunity via p65 deacetylation in pancreatic cancer. Theranostics. 12(5). 2080–2094. 47 indexed citations
7.
Wu, Wei, Zhenghao Zhang, Doudou Jing, et al.. (2022). SGLT2 inhibitor activates the STING/IRF3/IFN-β pathway and induces immune infiltration in osteosarcoma. Cell Death and Disease. 13(6). 523–523. 54 indexed citations
8.
Zhou, Chen, Dianyun Ren, Jie Chen, et al.. (2022). ITGA2 overexpression inhibits DNA repair and confers sensitivity to radiotherapies in pancreatic cancer. Cancer Letters. 547. 215855–215855. 11 indexed citations
9.
Liu, Wentao, Dianyun Ren, Wei Xiong, Xin Jin, & Liang Zhu. (2022). A novel FBW7/NFAT1 axis regulates cancer immunity in sunitinib-resistant renal cancer by inducing PD-L1 expression. Journal of Experimental & Clinical Cancer Research. 41(1). 38–38. 28 indexed citations
10.
Sun, Yan, Huan Zhang, Feng Guo, et al.. (2022). S-palmitoylation of PCSK9 induces sorafenib resistance in liver cancer by activating the PI3K/AKT pathway. Cell Reports. 40(7). 111194–111194. 89 indexed citations
11.
Guo, Feng, et al.. (2022). Overexpressed integrin alpha 2 inhibits the activation of the transforming growth factor β pathway in pancreatic cancer via the TFCP2-SMAD2 axis. Journal of Experimental & Clinical Cancer Research. 41(1). 73–73. 15 indexed citations
12.
Guo, Feng, Yingke Zhou, Hui Guo, et al.. (2021). NR5A2 transcriptional activation by BRD4 promotes pancreatic cancer progression by upregulating GDF15. Cell Death Discovery. 7(1). 78–78. 19 indexed citations
13.
Shen, Jian, Feng Guo, Yan Sun, et al.. (2021). Albumin Difference as a New Predictor of Postoperative Complications following Pancreatectomy. Digestive Surgery. 38(2). 166–174. 6 indexed citations
14.
Sun, Yan, Dianyun Ren, Yingke Zhou, et al.. (2021). Histone acetyltransferase 1 promotes gemcitabine resistance by regulating the PVT1/EZH2 complex in pancreatic cancer. Cell Death and Disease. 12(10). 878–878. 41 indexed citations
15.
Zhu, Shikai, Hongji Yang, Qiang Fu, et al.. (2021). Overexpressed WDR3 induces the activation of Hippo pathway by interacting with GATA4 in pancreatic cancer. Journal of Experimental & Clinical Cancer Research. 40(1). 88–88. 22 indexed citations
16.
Zhou, Chen, Zhiqiang Liu, Yingke Zhou, et al.. (2021). Prognostic Analysis of Different Metastatic Patterns in Invasive Intraductal Papillary Mucinous Neoplasm: A Surveillance, Epidemiology, and End Results Database Analysis. Canadian Journal of Gastroenterology and Hepatology. 2021(1). 4350417–4350417. 3 indexed citations
17.
Sun, Yan, Dianyun Ren, Chong Yang, et al.. (2021). TRIM15 promotes the invasion and metastasis of pancreatic cancer cells by mediating APOA1 ubiquitination and degradation. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1867(11). 166213–166213. 35 indexed citations
18.
Ren, Dianyun, Yan Sun, Dan Zhang, et al.. (2021). SGLT2 promotes pancreatic cancer progression by activating the Hippo signaling pathway via the hnRNPK-YAP1 axis. Cancer Letters. 519. 277–288. 40 indexed citations
19.
Zhang, Huan, Dianyun Ren, Xin Jin, & Heshui Wu. (2020). The prognostic value of modified Glasgow Prognostic Score in pancreatic cancer: a meta-analysis. Cancer Cell International. 20(1). 462–462. 28 indexed citations
20.
Ren, Dianyun, Jingyuan Zhao, Yan Sun, et al.. (2019). Overexpressed ITGA2 promotes malignant tumor aggression by up-regulating PD-L1 expression through the activation of the STAT3 signaling pathway. Journal of Experimental & Clinical Cancer Research. 38(1). 485–485. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026